stars 1 stars 2 stars 3

Bioptigen Inc. is an ISO 13485-certified medical device company that develops innovative ophthalmic imaging solutions. Bioptigen’s Envisu(tm) R-class systems are ideally suited to non-invasive ophthalmic imaging of animals ranging from zebrafish to elephants. Using low-power, near-infrared light, Envisu generates real-time, high-resolution, volumetric images of ocular microstructures from the cornea to the retina. Bioptigen has received CE approval to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical use within the EU.

Bioptigen, Inc. Questions

The Bioptigen, Inc. annual revenue was $6.1 million in 2026.

Frank Choe is the Director of Operations of Bioptigen, Inc..

2 people are employed at Bioptigen, Inc..

Bioptigen, Inc. is based in Morrisville, North Carolina.

The NAICS codes for Bioptigen, Inc. are [33, 339, 45].

The SIC codes for Bioptigen, Inc. are [59, 599].

Top Bioptigen, Inc. Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users